AT A GLANCE

AT A GLANCE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY * Charles Hancock, executive officer * Martin Gellert, president Nearly 3,000 members of ASBMB will attend the society's annual meeting May 21-25 at the Washington Convention Center in Washington, D.C. Presentations include almost 100 talks and more than 1,400 posters, as well as an exhibition. Meeting Highlights "The Washington Connection," a seri

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

* Charles Hancock, executive officer * Martin Gellert, president

Nearly 3,000 members of ASBMB will attend the society's annual meeting May 21-25 at the Washington Convention Center in Washington, D.C. Presentations include almost 100 talks and more than 1,400 posters, as well as an exhibition.

Meeting Highlights

"The Washington Connection," a series of public affairs sessions featuring: * "Science and Early Education," Bruce Alberts, president of the National Academy of Sciences, chairman (Sunday, 6:00 P.M.)

* "Science and Technology Transfer," Daniel Vapnek, senior vice president for research, Amgen Inc., Thousand Oaks, Calif., chairman (Monday, 6:00 P.M.)

* "Science and Public Policy," Howard Schachman, professor, emeritus, of molecular biology, University of California, Berkeley, chairman (Tuesday, 6:00 P.M.). Speakers will include Harold Varmus, director of the National Institutes of Health, and Neal Lane, director of the National Science Foundation.

AT A GLANCE

AMERICAN SOCIETY FOR MICROBIOLOGY

* Michael Goldberg, executive director * ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies